← Browse by Condition
Medical Condition

laryngeal disease

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for laryngeal disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — laryngeal disease Clinical Trials

How many clinical trials are currently recruiting for laryngeal disease?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for laryngeal disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for laryngeal disease?
laryngeal disease research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a laryngeal disease clinical trial?
Eligibility criteria for laryngeal disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Clinique Saint-Vincent 1 trial
Chung-Ang University Gwangmyeong Hospital 1 trial

Recruiting Clinical Trials

NCT06600919
Recruiting

Effect of Passive Music Therapy Via an App on Anxiety Prevention in ENT Surgery

Enrollment
500 pts
Location
Reunion
Sponsor
Clinique Saint-Vincent
View Trial →
NCT06507202 Phase 4
Recruiting

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

Enrollment
116 pts
Location
South Korea
Sponsor
Chung-Ang University Gwangmyeo...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology